In the early steady-state phase of RA, BM ILC2s contribute to BMMs differentiation to osteoclasts; however, in the active phase of RA, BM ILC2s suppress RANKL expression, BMMs differentiation into not osteoclasts, but M2 macrophage. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.